In this GEN webinar, Dr. Ryan Cawood describes how rethinking AAV manufacture “from the ground up”, allowed OXGENE™ to manipulate AAV’s natural relationship with adenovirus to address these challenges with their novel technology. The webinar will take a deep dive into the data behind this new technology, demonstrating how using these vectors can give a 40-fold improvement in AAV2 yield, alongside a 2000- fold increase in particle infectivity, establishing the potential for reduced cost of goods and improved safety for AAV based gene therapies.
Immune medicines, across cancers, infectious disease, and inflammatory disease, hold our closest promise to lasting curative therapies. In this sponsored webinar, IsoPlexis and various researchers will speak about the shift in space and time towards ‘Smaller’ to target our most powerful single cells, in order to accelerate timelines for finding these cures.
In this webinar—the third in the “Women in Science” series co-hosted by GEN and the Rosalind Franklin Society—renowned neuroscientist Dr. Susan Hockfield, who served as president of MIT from 2004–2012, will share her views of the future that she lays out in her recent book, The Age of Living Machines: How Biology Will Build the Next Technology Revolution.
In this GEN Keynote webinar, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research (CBER) at the FDA, will share how CBER is providing oversight to organizations during the critical developmental and manufacturing stages for biological products, as well as throughout the product life cycle.
In this GEN webinar, sponsored by Tecan, we will discuss the development of the FAST-HDR vector system (patent pending)—a novel set of plasmids to be used in combination with CRISPR for the rapid development of multi-tagged cell lines for drug discovery. These plasmids allow the insertion of protein tags in genes of interest for downstream applications such as high-content imaging or luminescence detection on live cells. We will present examples of the use of these enhanced cellular models for high-throughput screening, target characterization, and live-cell microscopy.
In this GEN webinar, our expert panelists will introduce bioSensAll™, an enhanced bystander bioluminescence resonance energy transfer (ebBRET)-based biosensor technology and its applications to interrogate RTK biology and expand current RTK drug discovery efforts.
On Demand Webinars
The Empowerment of Having a Lab of One’s Own: Continued Research on Cholera, Climate, and Human Health
In this webinar—the second in the “Women in Science” series co-hosted by GEN and the Rosalind Franklin Society—pioneering microbiologist and the first woman to lead the National Science Foundation, Rita Colwell, PhD, discusses her early work in bacteriology and discoveries about how cholera survives between epidemics, with its continuing relevance today in addressing contagion, ocean science , and climate change.
In this GEN webinar, sponsored by Horizon Discovery, we will hear from the experiences of two scientists working in different departments at Jounce Therapeutics that have integrated the CHOSOURCE platform to build efficiencies across their drug development workflow. Using their own experiences and case studies, our presenters will highlight the benefits of transient and stable transfections of CHO cell lines for various production purposes.
In this webinar—the first in a “Women in Science” series co-hosted by GEN and the Rosalind Franklin Society—British biologist and author Dr. Matthew Cobb explores Franklin’s contribution to DNA structure and how they have been seen in popular culture. He will equally focus on the other periods in her life, highlighting the insights they provide us into the mind of one of the 20th century’s greatest scientists, one who would have celebrated her hundredth birthday this year.
In this GEN webinar, sponsored by Unchained Labs, you will learn about some new tools and strategies to get you answers on empty/full ratio, quantification, aggregation, and the stability of your capsids with teeny-tiny sample volumes.
Kevin Davies, PhD, founding executive editor of The CRISPR Journal, has chronicled these events in his new book, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing. This GEN keynote webinar takes place on the official publication day of the book. Davies will share highlights and insights from his reporting over the past few years and consider some of the exciting new directions that CRISPR will empower in the years ahead.
In this GEN webinar, sponsored by Horizon Discovery, our presenters will discuss their process for evaluating growth conditions, transfection methods, clonal cell line development, and productivity assessments. We will also hear about the gene-editing options available to customize expression hosts to suit specific needs during discovery, development, and protein production.